Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes

被引:26
|
作者
Shah, BH [1 ]
Olivares-Reyes, JA [1 ]
Yesilkaya, A [1 ]
Catt, KJ [1 ]
机构
[1] NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1210/me.16.3.610
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The agonist-induced internalization of several G protein-coupled receptors is an obligatory requirement for their activation of MAPKs. Studies on the relationship between endocytosis of the angiotensin 11 (Ang 11) type 1 receptor (AT(1)-R) and Ang II-induced ERK1/2 activation were performed in clone 9 (C9) rat hepatic cells treated with inhibitors of endocytosis [sucrose, phenylarsine oxide (PAO), and concanavalin A]. Although Ang II-induced endocytosis of the AT(1)-R was prevented by sucrose and PAO, and was partially inhibited by concanavalin A, there was no impairment of Ang II-induced ERK activation. However, the specific epidermal growth factor receptor (EGF-R) kinase inhibitor, AG1478, abolished Ang II-induced activation of ERK1/2. Sucrose and PAO also inhibited EGF-induced internalization of the EGF-R in C9 cells, and the inability of these agents to impair EGF-induced ERK activation suggested that the latter is also independent of receptor endocytosis. In COS-7 cells transiently expressing the rat AT(1A)-R, Ang 11 also caused ERK activation through EGF-R transactivation. Furthermore, a mutant AT1A-R with truncated carboxyl terminus and impaired internalization retained full ability to activate ERK1/2 in response to Ang 11 stimulation. These findings demonstrate that Ang If-induced ERK1/2 activation in C9 hepatocytes is independent of both AT(1)-R and EGF-R endocytosis and is mediated by transactivation of the EGF-R.
引用
收藏
页码:610 / 620
页数:11
相关论文
共 50 条
  • [31] The mechanisms behind decreased internalization of angiotensin II type 1 receptor
    Bian, Jingwei
    Zhang, Suli
    Yi, Ming
    Yue, Mingming
    Liu, Huirong
    VASCULAR PHARMACOLOGY, 2018, 103 : 1 - 7
  • [32] INTERNALIZATION OF KCNQ1 PROTEIN BY ACTIVATION OF ANGIOTENSIN RECEPTOR TYPE 1
    Ishii, Kuniaki
    Norota, Ikuo
    Yamazaki, Yoshihiko
    Ohkura, Masamichi
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 256 - 256
  • [33] Molecular mechanisms underlying angiotensin II-induced angiotensin converting enzyme 2 internalization and degradation
    Ogunlade, Blessing
    Sriramula, Srinivas
    Lazartigues, Eric
    Guidry, Jessie J.
    Filipeanu, Catalin M.
    FASEB JOURNAL, 2017, 31
  • [34] Chronic angiotensin II infusion suppresses renal expression of angiotensin II type 1 receptor-interacting molecule ATRAP to decrease angiotensin II type 1 receptor internalization
    Tamura, Kouichi
    Wakui, Hiromichi
    Matsuda, Miyuki
    Dejima, Toru
    Shigenaga, Atsu-ichiro
    Masuda, Shin-ichiro
    Azuma, Koichi
    Maeda, Akinobu
    Kanaoka, Tomohiko
    Ohsawa, Masato
    Hirose, Tomonori
    Ishigami, Tomoaki
    Toya, Yoshiyuki
    Yabana, Machiko
    Umemura, Satoshi
    ENDOCRINE JOURNAL, 2010, 57 : S558 - S558
  • [35] Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase
    Choi, Hyun
    Leto, Thomas L.
    Hunyady, Laszlo
    Catt, Kevin J.
    Bae, Yun Soo
    Rhee, Sue Goo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (01) : 255 - 267
  • [36] Tyrosine 319 in the AT1 receptor is required far angiotensin II-induced activation of the EGF receptor
    Seta, K
    Sadoshima, J
    CIRCULATION, 1999, 100 (18) : 430 - 430
  • [37] Tissue-specific regulation of angiotensin II type 1 receptor-interacting molecule expression in angiotensin II-induced hypertension
    Wakui, H.
    Tamura, K.
    Matsuda, M.
    Shigenaga, A.
    Masuda, S. -i
    Azuma, K.
    Tsurumi-Ikeya, Y.
    Toya, Y.
    Minamisawa, S.
    Umemura, S.
    JOURNAL OF HYPERTENSION, 2008, 26 : S524 - S524
  • [38] Direct evidence for increased angiotensin II-induced cardiac angiotensin II type hydroxyl radicals in hypertrophy through 1a receptor
    Kakishita, M
    Nakamura, K
    Asanuma, M
    Morita, H
    Saito, H
    Kusano, K
    Nakamura, Y
    Emori, T
    Matsubara, H
    Sugaya, T
    Ogawa, N
    Ohe, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 : S67 - S70
  • [39] An essential role of angiotensin II type 1 receptor in the recipient arterial wall, not in bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis
    Koga, Junichiro
    Egashira, Kensuke
    Iwai, Masaru
    Horiuchi, Masatsugu
    Sunagawa, Kenji
    CIRCULATION, 2006, 114 (18) : 213 - 213
  • [40] Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging
    Schupp, Nicole
    Schmid, Ursula
    Rutkowski, Przemyslaw
    Lakner, Ursula
    Kanase, Nilesh
    Heidland, August
    Stopper, Helga
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (05) : F1427 - F1434